Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

New England Journal of Medicine

Volumn 349, Issue 22, 2003, Pages 2091-2098

  Forastiere, Arlene A ^a   Goepfert, Helmuth ^b   Maor, Moshe ^b   Pajak, Thomas F ^c   Weber, Randal ^b   Morrison, William ^b   Glisson, Bonnie ^b   Trotti, Andy ^d   Ridge, John A ^e   Chao, Clifford ^b   Peters, Glen ^f   Lee, Ding Jen ^a   Leaf, Andrea ^g   Ensley, John ^h   Cooper, Jay ⁱ  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c RADIATION THERAPY ONCOLOGY GROUP   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f The University of Alabama at Birmingham   (United States)

^g DEPARTMENT OF VETERANS AFFAIRS   (United States)

^h WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; HUMAN; INFECTION; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX PRESERVATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; ORGAN PRESERVATION; PHARYNX DISEASE; PRIORITY JOURNAL; RANDOMIZATION; SIDE EFFECT; SKIN DISEASE; STATISTICAL SIGNIFICANCE; STOMATITIS; SURVIVAL RATE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DEGLUTITION; FEMALE; FLUOROURACIL; HUMANS; LARYNGEAL NEOPLASMS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOTHERAPY; SPEECH; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0345714860     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa031317     Document Type: Article

References (11)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
3. Hong WK, Lippman SM, Wolf GT. Recent advances in head and neck cancer - larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1993;53:5113-20.
4. List MA, D'Antonio LL, Cella DF, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy - Head and Neck Scale: a study of utility and validity. Cancer 1996;77:2294-301.
5. Weymuller EA Jr, Alsarraf R, Yueh B, Deleyiannis FW, Coltrera MD. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 2001;127:489-93.
6. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis 1974;27:365-75.
7. Dunnett CW. A multiple comparison procedure from comparing several treatments with a control. J Am Stat Assoc 1955;50:1096-121.
8. Bristol DR. Designing clinical trials for two-sided multiple comparisons with a control. Control Clin Trials 1989;10:142-52.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
10. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
11. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.